Atlas currently has a purpose-built, 38,000 square foot laboratory where it can produce over 5,000 kg of dried cannabis annually as well as refine cannabis into isolated concentrates in mass capacity.
Further, Atlas Growers’ owns a 160-acre site that could allow for significant future expansion of cultivation capacity in Alberta, with a development permit in place for up to 1,000,000 square feet of additional construction. Atlas also owns 50% of Coastline Canada Inc., a late stage applicant with Health Canada that is anticipated to be licensed for cultivation on Vancouver Island in late 2019.
Atlas is well financed, raising over $25.6 million in equity to date, including $7.6 million related to acquisition of land and strategic investments, and also has available for future use a largely unutilized $6.25 million bank term loan facility.
Atlas Biotechnologies Inc. is currently privately held, and is conducting an additional private placement of common shares.